| 1 | Nucleotide Oligomerization Domain-like receptor 4 (NLR4) Gene Expression and Interleukin 1-β (IL 1-β) Level in Urine Samples Before and After Intravesical BCG Therapy For Treatment of Bladder Cancer. 2021;22:1141 doi: 10.15789/1563-0625-NOD-2101 |
| 2 | Lymphocyte-to-Monocyte Ratio (LMR) During Induction Is a Better Predictor Than Preoperative LMR in Patients Receiving Intravesical Bacillus Calmette -Guerin for Non-Muscle-Invasive Bladder Cancer. 2022;12: doi: 10.3389/fonc.2022.937638 |
| 3 | The Interplay between Oxidative Stress, Inflammation and Angiogenesis in Bladder Cancer Development. 2021;22:4483 doi: 10.3390/ijms22094483 |
| 4 | 100 years of Bacillus Calmette–Guérin immunotherapy: from cattle to COVID-19. 2021;18:611 doi: 10.1038/s41585-021-00481-1 |
| 5 | Trained immunity: A Yin‐Yang balance. 2022;3: doi: 10.1002/mco2.121 |
| 6 | Trained immunity as a molecular mechanism for BCG immunotherapy in bladder cancer. 2020;17:513 doi: 10.1038/s41585-020-0346-4 |
Journal of Cancer Metastasis and Treatment
